Get started
Author

Nalini Raghunathan

Observed name: N Raghunathan
ORCID: 0000-0001-7864-8534
Observed ORCID: 0000-0001-7864-8534
OpenAlex ID: A5011640432
A new role for Escherichia coli Dam DNA methylase in prevention of aberrant chromosomal replication
2019 · Nalini Raghunathan, Sayantan Goswami, et al. · Nucleic Acids Research · 38
PDF
Genome-wide relationship between R-loop formation and antisense transcription in Escherichia coli
2018 · Nalini Raghunathan, Rajvardhan M Kapshikar, et al. · Nucleic Acids Research · 38
PDF
Topoisomerase I Essentiality, DnaA-Independent Chromosomal Replication, and Transcription-Replication Conflict in Escherichia coli
2021 · J Krishna Leela, Nalini Raghunathan, et al. · Journal of Bacteriology · 22
PDF
Tofacitinib use in ulcerative colitis: An expert consensus for day-to-day clinical practice
2024 · Rupa Banerjee, Vishal Sharma, et al. · Indian Journal of Gastroenterology · 17
Managing inflammatory bowel disease: what to do when the best is unaffordable?
2023 · Rupa Banerjee, Nalini Raghunathan, et al. · The Lancet. Gastroenterology & hepatology · 14
Primary caregiver burden and undiagnosed mental health illness in out-patients with inflammatory bowel disease—A multicentric prospective survey from the IBD Emerging Nations’ Consortium
2024 · Rupa Banerjee, Partha Pal, et al. · Indian Journal of Gastroenterology · 10
P1343 Impact of Biologic Therapy on Gut Microbiome in Crohn's Disease: An Indian Patient Cohort Study
2025 · N Raghunathan, N Gunala, et al. · Journal of Crohn s and Colitis · 2
Editorial: a paradigm shift in NUDT15 assessment—towards predictive and personalised medicine in Crohn’s disease?
2022 · Rupa Banerjee, Nalini Raghunathan · Alimentary Pharmacology & Therapeutics · 2
PDF
P0905 The Mediterranean diet improves clinical and inflammatory outcomes in patients with early Crohn’s Disease: Results from the IBDMED randomized controlled trial
2026 · L Godny, N Raghunathan, et al. · Journal of Crohn s and Colitis · 1
PDF
Distinguishing Crohn’s Disease From Non–Crohn’s Ileitis: A Gut Microbiome–Based Approach
2025 · Nalini Raghunathan, Varun Joshi, et al. · Advanced Gut & Microbiome Research · 1
PDF
Editorial: When the Diagnosis is Uncertain, Can AI be Certain Enough?
2026 · Rupa Banerjee, Nalini Raghunathan · Alimentary Pharmacology & Therapeutics
PDF
917 the Mediterranean Diet Improves Clinical and Inflammatory Outcomes in Patients With Early Crohn’s Disease: Results From the Ibdmed Randomized Controlled Trial
2026 · Lihi Godny, Nalini Raghunathan, et al. · Gastroenterology
104 Rapid Urbanisation and Ibd Prevalence in Rural India: Insights From a Satellite Based Deep Learning Index
2026 · Rupa Banerjee, Nalini Raghunathan, et al. · Gastrointestinal Endoscopy
Mo1606 THE MEDITERRANEAN DIET IN PATIENTS WITH EARLY CROHN’S DISEASE- FEASIBILITY AND DRIVERS OF ADHERENCE IN ISRAEL AND INDIA: RESULTS FROM THE IBDMED RANDOMIZED CONTROLLED TRIAL
2026 · Shelly R. Shakhman, Sarine Elial-Fatal, et al. · Gastrointestinal Endoscopy
104 Rapid Urbanisation and Ibd Prevalence in Rural India: Insights From a Satellite Based Deep Learning Index
2026 · Rupa Banerjee, Nalini Raghunathan, et al. · Gastroenterology
Mo1606 THE MEDITERRANEAN DIET IN PATIENTS WITH EARLY CROHN’S DISEASE- FEASIBILITY AND DRIVERS OF ADHERENCE IN ISRAEL AND INDIA: RESULTS FROM THE IBDMED RANDOMIZED CONTROLLED TRIAL
2026 · Shelly R. Shakhman, Sarine Elial-Fatal, et al. · Gastroenterology
917 the Mediterranean Diet Improves Clinical and Inflammatory Outcomes in Patients With Early Crohn’s Disease: Results From the Ibdmed Randomized Controlled Trial
2026 · Lihi Godny, Nalini Raghunathan, et al. · Gastrointestinal Endoscopy
P1293 Rapid Urbanisation and IBD Prevalence in Rural India: Insights from a Satellite Based Deep Learning Index
2026 · R Banerjee, N Raghunathan, et al. · Journal of Crohn s and Colitis
PDF
P1322 IBD, IBS, and Functional Dyspepsia: Differentiating The Spectrum via Microbiome based Machine Learning Approach
2026 · M Thakur, N Raghunathan, et al. · Journal of Crohn s and Colitis
PDF
P1323 Akkermansia and Gut Microbial SNP Signatures as Determinants of Ustekinumab Treatment Outcomes in Crohn’s Disease
2026 · N Raghunathan, N Gunala, et al. · Journal of Crohn s and Colitis
PDF
DOP002 The Mediterranean diet in patients with early Crohn’s disease - feasibility and drivers of adherence in Israel and India: Results from the IBDMED randomized controlled trial
2026 · S Shakhman, S Elial-Fatal, et al. · Journal of Crohn s and Colitis
PDF
P0120 Lifestyle and Geographic Influences Shape Gut Enterotypes and Microbial Dysbiosis in Inflammatory Bowel Disease
2026 · N Gunala, N Raghunathan, et al. · Journal of Crohn s and Colitis
50: Degree of Urbanization and Environmental Risk Factors Associated With Inflammatory Bowel Disease(ibd) in Rural India: a House-to-house Survey of Over 100,000 Village Population in the State of Telangana
2025 · Rupa Banerjee, Partha Pal, et al. · Gastroenterology
747: Efficacy and Safety of Vedolizumab and Tofacitinib (veto) Combination Therapy in Refractory Ulcerative Colitis Unresponsive to Anti-tnfs and a Second-line Advanced Therapy
2025 · Pardhu Bharath, Rajender Patel, et al. · Gastroenterology
P1348 Unique gut microbiome profile can distinguish Intestinal Tuberculosis and Crohn`s Disease: An Indian patient cohort study
2025 · N Raghunathan, M Thakur, et al. · Journal of Crohn s and Colitis
PDF
Works count: 34
Citation count: 145
H-index: 6
I10-index: 6
Year
Topic
Type